2) serum hepatic fibrosis index
血清肝纤维化指标
1.
Their plasma endotoxin levels were measured with chromogenic limulus amebocyte lysate method and their serum hepatic fibrosis indexes (HA, LN, PC-Ⅲ and Ⅳ-C) were measured with radioimmunoassay method.
方法 选择慢性肝炎患者 75例和体检正常健康者 15例 ,均采用基质显色法检测血浆内毒素 (ET)水平 ,放射免疫法测定血清肝纤维化指标(HA、LN、PC -Ⅲ和Ⅳ -C) ,并对其中 2 0例患者行肝组织活检。
4) Serum fibrosis markers
血清学纤维化指标
1.
Methods Portal vein blood flow velocity(PBFVe)and volume(PBFVo) along with the serum fibrosis markers were examined in 71 patients with chronic viral hepatitis B, and hepatic pathological changes were routinely observed.
方法测定71例慢性乙型肝炎患者门脉血流速度(portal blood velocity, PBFVe)、门脉血流量(portal blood flow, PBFVo)和血清学纤维化指标并观察肝组织的病理改变情况。
6) serum fibrosis marker
血清纤维指标
1.
Objective To investigate the clinical significance of changes of serum fibrosis marker in pulmonary tuberculosis patients.
目的探讨肺结核患者血清纤维指标变化的临床意义。
补充资料：纤维化
纤维化
fibratkn
病变组织或器官发生纤维组织增生的过程，常是变性炎症、缺血、坏死、创伤等引起的后果。如创伤后伤口内产生肉芽组织并逐渐转为纤维化，最后形成瘢痕。发生在内脏器官(如心、肺、肝等）的弥漫性纤维化，可引起脏器变形、变硬，故有硬化之称，如肝硬化。纤维化的后果按其发生部位及范围而异，如皮肤局限性纤维化的影响较小；而心瓣膜的纤维化或瘢痕形成，常引起瓣膜变形，形成狭窄和闭锁不全，导致心力衰竭。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条